AI using non-contrast breast MRI for early screening
Part of Cancer clinical trials.
This study tests an AI tool that reads non-contrast breast MRI images to help find breast cancer earlier, especially in women who can't have contrast dye. You don't get extra scans — the AI reviews your existing MRI and checks its accuracy against your medical outcome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women aged 30 to 70 years
- Had a breast MRI that included T2WI, DWI, and ADC sequences
- All scans and clinical follow-up done within 90 days of each other
- A clear breast health outcome: either a biopsy-proven diagnosis or a follow-up showing no cancer for at least 12–24 months
- No MRI contraindications like a pacemaker, cochlear implant, or metal in the eye
- Not pregnant or breastfeeding, and no recent breast surgery, radiation, or imaging after neoadjuvant therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new artificial intelligence software called Kenko Breast AI+ that analyzes breast MRI scans to help doctors better detect and monitor breast cancer. If you've had or are planning to have a breast MRI for cancer concerns, this trial might be right for you.
This study uses artificial intelligence to look at chest CT scans taken during routine health check-ups to find early signs of breast cancer. It may help improve early detection without extra scans.
This study tests a new way to read breast MRI images without using a contrast dye. It aims to see if this method can accurately find breast cancer and reduce the need for injections.
This study tests whether artificial intelligence (AI) can help radiologists read mammograms (breast X-rays) more accurately during routine breast cancer screening. It aims to see if AI can catch more cancers early while reducing unnecessary follow-up exams.
This trial uses an AI model called Mirai to identify women at high risk for breast cancer based on their mammograms. If you are eligible, you may be invited for a breast MRI to better understand your risk.
This study compares a single radiologist reading your mammogram with help from artificial intelligence (AI) to the standard method of two radiologists reading it. The goal is to see if AI-assisted reading is just as good at finding cancer while saving time and resources.
Hear when a new Breast Cancer Detection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.